Once again, I understand why EPS is what it is, but companies give both revenue and EPS guidance all the time. No excuse for missing consensus EPS by 30+% on an ongoing basis. Clear guidance it's not.
I understand the what and why, it's the how of late I have an issue with.
Perhaps we can agree at least that with the obvious expansions being planned on multiple fronts it's time for JC to take off two of his hat's and hire a topnotch COO and CCO, or hic-ups will continue. Lost two really good ones.
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt, page-34
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
0.010(0.41%) |
Mkt cap ! $160.4M | |||
| Open | High | Low | Value | Volume |
| $2.42 | $2.45 | $2.41 | $562.3K | 231.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 82002 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 16 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |